Gene · 347527
Papers1,787
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,787
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of steroidal molecules for targeted breast cancer therapy: Endocrine resistance and innovative drug design. | J Steroid Biochem Mol Biol | 2027 | 42567417 | PubTator, text mining | PubMed |
| An advocacy for investigation of a "new" estrogen metabolite as a stable epoxide. | J Steroid Biochem Mol Biol | 2027 | 42567416 | PubTator, text mining | PubMed |
| PBPK modeling of intravenous/oral acetaminophen in healthy and pregnant individuals. | Pak J Pharm Sci | 2026 | 42708778 | PubTator, text mining | PubMed |
| Cysteine Thioaldehydes: Photolytic Generation, Reactivity, and Biological Implications. | Angew Chem Int Ed Engl | 2026 | 42605888 | PubTator, text mining | PubMed |
| Estrogen Receptors and Enzymes Involved in Estrogen Synthesis as Breast Cancer Treatment Targets. | Int J Mol Sci | 2026 | 42589479 | PubTator, text mining | PubMed |
| New Structures of Human Formylglycine-generating Enzyme Reveal Features Important for Catalysis, Disease and Structure-based Drug Design. | J Mol Biol | 2026 | 42580400 | PubTator, text mining | PubMed |
| Functional gene dynamics and methane cycling across vegetation types in coastal soils of Gujarat, India. | Environ Sci Pollut Res Int | 2026 | 42518122 | PubTator, text mining | PubMed |
| Engineering gut microbiota-derived enzymes for glycosaminoglycan metabolism: Catalytic mechanisms, diversity, and technologies. | Biotechnol Adv | 2026 | 42413634 | PubTator, text mining | PubMed |
| Urinary volatile organic compounds as potential non-invasive markers for childhood obesity. | Metabolomics | 2026 | 42384279 | PubTator, text mining | PubMed |
| Fluoro arylsulfates: kinetic analysis reveals new possibilities with sulfatase-cleavable linkers in ADCs. | Chem Commun (Camb) | 2026 | 42367150 | PubTator, text mining | PubMed |
| Chemoenzymatic Synthesis of Asymmetric N-Glycans in Aqueous Solution via Sulfate and Phosphate Orthogonal Protection. | J Am Chem Soc | 2026 | 42329121 | PubTator, text mining | PubMed |
| Fluorogenic Coupled Assays Reveal Catalytic Properties, Inhibition Constants and Cellular Location of Mucin-Active Carbohydrate Sulfatases. | Angew Chem Int Ed Engl | 2026 | 42175861 | PubTator, text mining | PubMed |
| Arylsulfatase L is a Golgi chondroitin sulfatase regulating skeletal development. | J Biol Chem | 2026 | 42103217 | PubTator, text mining | PubMed |
| Expression of sulfate pathway genes in human neurodevelopment. | J Neurogenet | 2026 | 42101182 | PubTator, text mining | PubMed |
| Clinical and Molecular Characterization of Pakistani Mucopolysaccharidosis Families with SGSH and GALNS Deficiencies. | Genes (Basel) | 2026 | 42074519 | PubTator, text mining | PubMed |
| Newly isolated human-derived Lactobacillus fermentum strain stimulates IFN-γ-secreting CD8+ T cells for enhanced anti-cancer immunity. | iScience | 2026 | 42063558 | PubTator, text mining | PubMed |
| Conserved glycan-utilization strategies shape Akkermansiaceae success across aquatic and gut ecosystems. | ISME J | 2026 | 42017823 | PubTator, text mining | PubMed |
| Human Gut Microbiome Can Degrade the Sweetener Acesulfame K with Potential Damaging Effects in the Intestinal Barrier Function. | J Agric Food Chem | 2026 | 42012901 | PubTator, text mining | PubMed |
| Sulfur as a central integrator of plant-microbe interactions: from nutrient cycling to immune signalling and microbiome assembly. | J Exp Bot | 2026 | 41995611 | PubTator, text mining | PubMed |
| Engineering the holobiont: Synthetic biology strategies for reversing bioenergetic collapse in radiation enteritis. | AIMS Microbiol | 2026 | 41938784 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/347527/papers